Cliff Asness's RPRX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.96 M shares of Royalty Pharma plc (RPRX) worth $69.19 M, representing 0.04% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in RPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 1.24 M shares. Largest reduction occurred in Q2 2025, reducing 871,815 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Royalty Pharma plc (RPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Royalty Pharma plc (RPRX) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +187,556 | New Buy | 187,556 | $30.40 |
| Q3 2023 | +448,127 | Add 238.93% | 635,683 | $26.76 |
| Q4 2023 | -204,722 | Reduce 32.21% | 430,961 | $27.98 |
| Q1 2024 | +34,000 | Add 7.89% | 464,961 | $30.37 |
| Q2 2024 | +320,606 | Add 68.95% | 785,567 | $26.37 |
| Q3 2024 | -122,275 | Reduce 15.57% | 663,292 | $28.21 |
| Q4 2024 | +1.24 M | Add 187.00% | 1.9 M | $25.51 |
| Q1 2025 | +704,414 | Add 37.00% | 2.61 M | $30.82 |
| Q2 2025 | -871,815 | Reduce 33.43% | 1.74 M | $35.79 |
| Q3 2025 | +224,811 | Add 12.95% | 1.96 M | $35.28 |
Cliff Asness's Royalty Pharma plc Investment FAQs
Cliff Asness first purchased Royalty Pharma plc (RPRX) in Q2 2023, acquiring 187,556 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Royalty Pharma plc (RPRX) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Royalty Pharma plc (RPRX) was in Q4 2024, adding 1,903,676 shares worth $48.56 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,961,086 shares of Royalty Pharma plc (RPRX), valued at approximately $69.19 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Royalty Pharma plc (RPRX) represents approximately 0.04% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Royalty Pharma plc (RPRX) was 2,608,090 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.